Cargando…

Autophagy Modulators in Cancer: Focus on Cancer Treatment

Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains di...

Descripción completa

Detalles Bibliográficos
Autor principal: Nam, Hye Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401266/
https://www.ncbi.nlm.nih.gov/pubmed/34440583
http://dx.doi.org/10.3390/life11080839
_version_ 1783745510143688704
author Nam, Hye Jin
author_facet Nam, Hye Jin
author_sort Nam, Hye Jin
collection PubMed
description Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains difficult to equally apply autophagy modulators to cancer therapy because autophagy is a double-edged sword in cancer: it can be tumor-suppressive or tumor-protective. Therefore, the precise mechanisms of autophagy modulators and their varied responsiveness to each cancer type should be addressed in detail. This study will describe the precise mechanisms of developing various autophagy modulators, their current therapeutic applications and future perspectives.
format Online
Article
Text
id pubmed-8401266
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84012662021-08-29 Autophagy Modulators in Cancer: Focus on Cancer Treatment Nam, Hye Jin Life (Basel) Review Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains difficult to equally apply autophagy modulators to cancer therapy because autophagy is a double-edged sword in cancer: it can be tumor-suppressive or tumor-protective. Therefore, the precise mechanisms of autophagy modulators and their varied responsiveness to each cancer type should be addressed in detail. This study will describe the precise mechanisms of developing various autophagy modulators, their current therapeutic applications and future perspectives. MDPI 2021-08-17 /pmc/articles/PMC8401266/ /pubmed/34440583 http://dx.doi.org/10.3390/life11080839 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nam, Hye Jin
Autophagy Modulators in Cancer: Focus on Cancer Treatment
title Autophagy Modulators in Cancer: Focus on Cancer Treatment
title_full Autophagy Modulators in Cancer: Focus on Cancer Treatment
title_fullStr Autophagy Modulators in Cancer: Focus on Cancer Treatment
title_full_unstemmed Autophagy Modulators in Cancer: Focus on Cancer Treatment
title_short Autophagy Modulators in Cancer: Focus on Cancer Treatment
title_sort autophagy modulators in cancer: focus on cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401266/
https://www.ncbi.nlm.nih.gov/pubmed/34440583
http://dx.doi.org/10.3390/life11080839
work_keys_str_mv AT namhyejin autophagymodulatorsincancerfocusoncancertreatment